Cargando…
No benefit of hydroxychloroquine on SARS-CoV-2 viral load reduction in non-critical hospitalized patients with COVID-19
BACKGROUND: Some studies have shown that hydroxychloroquine (HCQ) is an effective drug in reducing the in vitro replication of SARS-CoV-2. However, the in vivo effect of HCQ still unclear. OBJECTIVES: This study aims to evaluate viral load clearance in patients with COVID-19 who underwent HCQ treatm...
Autores principales: | Faíco-Filho, Klinger Soares, Conte, Danielle Dias, de Souza Luna, Luciano Kleber, Carvalho, Joseane Mayara Almeida, Perosa, Ana Helena Sitta, Bellei, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592126/ https://www.ncbi.nlm.nih.gov/pubmed/33111169 http://dx.doi.org/10.1007/s42770-020-00395-x |
Ejemplares similares
-
Comparative analysis of three point-of-care lateral flow immunoassays for detection of anti-SARS-CoV-2 antibodies: data from 100 healthcare workers in Brazil
por: Conte, Danielle Dias, et al.
Publicado: (2021) -
COVID-19 in health care workers in a university hospital during the quarantine in São Paulo city
por: Faíco-Filho, Klinger Soares, et al.
Publicado: (2020) -
Different patterns of Influenza A and B detected during early stages of COVID-19 in a university hospital in São Paulo, Brazil
por: de Souza Luna, Luciano Kleber, et al.
Publicado: (2020) -
ALTERAÇÃO DE MARCADORES LABORATORIAIS EM PACIENTES INTERNADOS POR COVID‐19
por: Chaves, Ana Paula Cunha, et al.
Publicado: (2021) -
Test on stool samples improves the diagnosis of hospitalized patients: Detection of SARS-CoV-2 genomic and subgenomic RNA
por: Moreira, Luiz Vinicius Leão, et al.
Publicado: (2021)